Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma.

[1]  M. Tomonaga,et al.  Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma. , 2006, Cancer letters.

[2]  P. Pandolfi,et al.  The transcription factor Pokemon: a new key player in cancer pathogenesis. , 2005, Cancer research.

[3]  M. Matsuoka,et al.  Natural history of adult T-cell leukemia/lymphoma and approaches to therapy , 2005, Oncogene.

[4]  Jun Qin,et al.  ARF-BP1/Mule Is a Critical Mediator of the ARF Tumor Suppressor , 2005, Cell.

[5]  P. Pandolfi,et al.  Role of the proto-oncogene Pokemon in cellular transformation and ARF repression , 2005, Nature.

[6]  Chih-Yi Chen,et al.  CpG Island Methylation Is Responsible for p14ARF Inactivation and Inversely Correlates with p53 Overexpression in Resected Non–Small Cell Lung Cancer , 2004, Clinical Cancer Research.

[7]  R. Fukumoto,et al.  T-Cell Control by Human T-Cell Leukemia/Lymphoma Virus Type 1 , 2003, International journal of hematology.

[8]  Y. Katayama,et al.  Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  M. Tomonaga,et al.  Interruption of p16 gene expression in adult T‐cell leukaemia/lymphoma: clinical correlation , 2003, British journal of haematology.

[10]  M. Tomonaga,et al.  The Current Status of Therapy for Adult T-cell Leukaemia-Lymphoma in Japan , 2003, Leukemia & lymphoma.

[11]  M. Matsuoka.  SOMATIC ALTERATIONS IN ADULT T-CELL LEUKEMIA CELLS , 2003 .

[12]  Carl W. Miller,et al.  Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors , 2002, Oncogene.

[13]  K. Yamaguchi,et al.  5′-Long Terminal Repeat-Selective CpG Methylation of Latent Human T-Cell Leukemia Virus Type 1 Provirus In Vitro and In Vivo , 2002, Journal of Virology.

[14]  P. Pandolfi,et al.  The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia , 2002, Nature Medicine.

[15]  H. Koeffler,et al.  Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL) , 2002, Leukemia.

[16]  K. Matsushima,et al.  Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. , 2002, Blood.

[17]  N. Tsuchida,et al.  Selective deletion of p14(ARF) exon 1beta of the INK4a locus in oral squamous cell carcinomas of Indians. , 2001, Oral oncology.

[18]  G. Stark,et al.  Regulation of the G2/M transition by p53 , 2001, Oncogene.

[19]  J. Bartek,et al.  Pathways governing G1/S transition and their response to DNA damage , 2001, FEBS letters.

[20]  W. Hofmann,et al.  Methylation Analysis of Cell Cycle Control Genes in Adult T-Cell Leukemia/Lymphoma , 2001, Leukemia & lymphoma.

[21]  M. Roussel,et al.  p53-independent functions of the p19(ARF) tumor suppressor. , 2000, Genes & development.

[22]  T. Waldmann,et al.  p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells. , 2000, Blood.

[23]  G. Yang,et al.  Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  A. Kukita,et al.  Osteoclast-Derived Zinc Finger (OCZF) Protein With POZ Domain, a Possible Transcriptional Repressor, Is Involved in Osteoclastogenesis , 1999 .

[25]  D. Leprince,et al.  Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene , 1999, Oncogene.

[26]  Peter A. Jones,et al.  The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53 , 1998, Molecular and Cellular Biology.

[27]  M. Serrano,et al.  p19ARF links the tumour suppressor p53 to Ras , 1998, Nature.

[28]  Kevin Ryan,et al.  The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 , 1998, The EMBO journal.

[29]  Ken Chen,et al.  The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.

[30]  Richard A. Ashmun,et al.  Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.

[31]  N. Hernandez,et al.  Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts , 1997, Molecular and cellular biology.

[32]  M. Tomonaga,et al.  Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[34]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[35]  F. Zindy,et al.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.

[36]  C. D. Edwards,et al.  A novel p16INK4A transcript. , 1995, Cancer research.

[37]  M. Tomonaga,et al.  Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. , 1995, Blood.

[38]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[39]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[40]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[41]  N. Miyamoto,et al.  RISK OF ADULT T-CELL LEUKAEMIA/LYMPHOMA IN HTLV-I CARRIERS , 1987, The Lancet.

[42]  J. Dooley,et al.  α1-ANTITRYPSIN DEFICIENCY AND LIVER DISEASE , 1982, The Lancet.

[43]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[44]  J. Yodoi,et al.  Adult T-cell leukemia: clinical and hematologic features of 16 cases. , 1977, Blood.